Journal of Neurology

, Volume 261, Issue 4, pp 784–790 | Cite as

White matter lesions in chronic migraine with medication overuse headache: a cross-sectional MRI study

Original Communication

Abstract

Analgesic overuse often happens to migraine patients, especially chronic migraineurs, and migraine has been demonstrated to be associated with white matter lesions (WMLs). The aim of this study was to investigate the relationship between medication overuse headache (MOH) and WMLs in chronic migraine (CM) patients. Subjects were enrolled and divided into three groups: healthy controls, CM without MOH (CMwoMOH), and CM with MOH (CM-MOH). Most of the CM patients used non-steroidal anti-inflammatory drugs (NSAIDs) as acute headache medications. All the participants underwent magnetic resonance imaging scans and images were obtained for WML evaluation with semiquantitative scales. One hundred and forty-one participants were included, 45 of them for controls, 38 for CMwoMOH, and 58 for CM-MOH. In women, CMwoMOH patients had a higher prevalence of high WML load compared with controls and CM-MOH patients. In men, however, all the study groups showed no differences in the prevalence of high WML load. CMwoMOH women had increased risks of high deep white matter lesion (DWML) load compared with controls, while they had no risks of high periventricular white matter lesion (PVWML) load. CM-MOH women had no risks of high DWML load, but they had reduced risks of high PVWML load. The association of CM-MOH with high WML load in women was not changed when compared with CMwoMOH. Age was independently associated with high WML load among women. These data suggest that MOH caused by NSAIDs is not a risk factor for WMLs. Rather, NSAID overuse probably protects MOH patients from WMLs through anti-inflammatory effects.

Keywords

Medication overuse headache Chronic migraine White matter lesions Risk factors Magnetic resonance imaging 

References

  1. 1.
    Adami A, Rossato G, Cerini R, Thijs VN, Pozzi-Mucelli R, Anzola GP, Del SM, Finocchi C, Meneghetti G, Zanferrari C (2008) Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 71:101–107CrossRefPubMedGoogle Scholar
  2. 2.
    Chiapparini L, Ferraro S, Grazzi L, Bussone G (2010) Neuroimaging in chronic migraine. Neurol Sci 31(Suppl 1):S19–S22CrossRefPubMedGoogle Scholar
  3. 3.
    de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM (2001) Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 70:9–14PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Di W, Shi X, Zhu Y, Tao Y, Qi W, Luo N, Xiao Z, Yi C, Miao J, Zhang A, Zhang X, Fang Y (2013) Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients. Eur J Neurol 20:655–662CrossRefPubMedGoogle Scholar
  5. 5.
    Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9:391–401CrossRefPubMedGoogle Scholar
  6. 6.
    Ferraro S, Grazzi L, Mandelli ML, Aquino D, Di Fiore D, Usai S, Bruzzone MG, Di Salle F, Bussone G, Chiapparini L (2012) Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med 13:255–262CrossRefPubMedGoogle Scholar
  7. 7.
    Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129:543–550CrossRefPubMedGoogle Scholar
  8. 8.
    Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ (1990) The mini-mental state examination in the early diagnosis of Alzheimer’s disease. Arch Neurol 47:49–52CrossRefPubMedGoogle Scholar
  9. 9.
    Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR (2005) CGRP and migraine: neurogenic inflammation revisited. J Headache Pain 6:61–70PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Gupta VK (2009) CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother 9:1595–1614CrossRefPubMedGoogle Scholar
  11. 11.
    Kara B, Kiyat AA, Onat L, Ulusoy L, Mutlu A, Sirvanci M (2013) DTI findings during spontaneous migraine attacks. Clin Neuroradiol 23:31–36CrossRefPubMedGoogle Scholar
  12. 12.
    Kruit MC, Thijs RD, Ferrari MD, Launer LJ, van Buchem MA, van Dijk JG (2013) Syncope and orthostatic intolerance increase risk of brain lesions in migraineurs and controls. Neurology 80:1958–1965PubMedCentralCrossRefPubMedGoogle Scholar
  13. 13.
    Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427–434CrossRefPubMedGoogle Scholar
  14. 14.
    Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD (2010) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 30:129–136PubMedCentralPubMedGoogle Scholar
  15. 15.
    Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, Bousser MG, Dufouil C, Tzourio C (2011) Headache, migraine, and structural brain lesions and function: population based epidemiology of vascular ageing-MRI study. BMJ 342:c7357PubMedCentralCrossRefPubMedGoogle Scholar
  16. 16.
    Miller SP, Mayer EE, Clyman RI, Glidden DV, Hamrick SE, Barkovich AJ (2006) Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks’ gestation at birth. Pediatrics 117:1626–1631CrossRefPubMedGoogle Scholar
  17. 17.
    Morales OY, Jinka M, Ziai WC (2010) Severe leukoencephalopathy following acute oxycodone intoxication. Neurocrit Care 13:93–97CrossRefGoogle Scholar
  18. 18.
    Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746CrossRefPubMedGoogle Scholar
  19. 19.
    Palm-Meinders IH, Koppen H, Terwindt GM, Launer LJ, Konishi J, Moonen JM, Bakkers JT, Hofman PA, van Lew B, Middelkoop HA, van Buchem MA, Ferrari MD, Kruit MC (2012) Structural brain changes in migraine. JAMA 308:1889–1897PubMedCentralCrossRefPubMedGoogle Scholar
  20. 20.
    Park HK, Lee SY, Kim SE, Yun CH, Kim SH (2011) Small deep white matter lesions are associated with right-to-left shunts in migraineurs. J Neurol 258:427–433CrossRefPubMedGoogle Scholar
  21. 21.
    Rozen TD (2010) Images from headache: white matter lesions of migraine are not static. Headache 50:305–306CrossRefPubMedGoogle Scholar
  22. 22.
    Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM (2010) Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. AJNR Am J Neuroradiol 31:565–566CrossRefPubMedGoogle Scholar
  23. 23.
    Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, van Buchem MA (2008) Attack frequency and disease duration as indicators for brain damage in migraine. Headache 48:1044–1055CrossRefPubMedGoogle Scholar
  24. 24.
    Seet RC, Rathakrishnan R, Chan BP, Lim EC (2005) Diffuse cystic leucoencephalopathy after buprenorphine injection. J Neurol Neurosurg Psychiatry 76:890–891PubMedCentralCrossRefPubMedGoogle Scholar
  25. 25.
    Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ (2005) The international classification of headache disorders, 2nd edn. (ICHD-II): revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 25:460–465Google Scholar
  26. 26.
    Swartz RH, Kern RZ (2004) Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 61:1366–1368CrossRefPubMedGoogle Scholar
  27. 27.
    Trauninger A, Leel-Ossy E, Kamson DO, Poto L, Aradi M, Kover F, Imre M, Komaromy H, Erdelyi-Botor S, Patzko A, Pfund Z (2011) Risk factors of migraine-related brain white matter hyperintensities: an investigation of 186 patients. J Headache Pain 12:97–103PubMedCentralCrossRefPubMedGoogle Scholar
  28. 28.
    Turkoglu R, Tuzun E, Icoz S, Birisik O, Erdag E, Kurtuncu M, Akman-Demir G (2011) Antineuronal antibodies in migraine patients with white matter lesions. Int J Neurosci 121:33–36CrossRefPubMedGoogle Scholar
  29. 29.
    Wakita H, Tomimoto H, Akiguchi I, Lin JX, Miyamoto K, Oka N (1999) A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia. NeuroReport 10:1461–1465CrossRefPubMedGoogle Scholar
  30. 30.
    Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D (2007) Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 211:23–30CrossRefPubMedGoogle Scholar
  31. 31.
    Yoon GJ, Kim JT, Chang J, Kim DE, Cho BH, Lee JH, Jung HJ, Lee SH, Choi SM, Park MS, Cho KH (2012) Right-to-left shunts as a cause of juxtacortical spots in patients with migraine. Eur J Neurol 19:1086–1092CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Zhenyang Zheng
    • 1
  • Zijian Xiao
    • 1
  • Xiaolei Shi
    • 1
  • Minghui Ding
    • 2
  • Wei Di
    • 3
  • Weiwei Qi
    • 1
  • Aiwu Zhang
    • 1
  • Yannan Fang
    • 1
  1. 1.Guangdong Key Laboratory for Diagnosis and Treatment of Major Neurological Diseases, Department of Neurology, The First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  2. 2.Department of Rehabilitation, The First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  3. 3.Department of NeurologyShaanxi Provincial People’s HospitalXi’anChina

Personalised recommendations